Cencora Inc.(COR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

COR Cencora Inc.

Closed Good Friday 04-17 16:00:00 EDT

286.74

+2.30

+0.81%

盘后287.35

+0.61+0.21%

19:55 EDT

High287.84	Low281.65	Vol1.62M
Open283.01	D1 Closing284.44	Amplitude2.18%
Mkt Cap55.60B	Tradable Cap52.39B	Total Shares193.92M
T/O463.05M	T/O Rate0.89%	Tradable Shares182.70M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"COR","market":"US","secType":"STK","nameCN":"Cencora Inc.","latestPrice":286.74,"timestamp":1744920000000,"preClose":284.44,"halted":0,"volume":1617549,"hourTrading":{"tag":"盘后","latestPrice":287.35,"preClose":286.74,"latestTime":"19:55 EDT","volume":58970,"amount":16911212.395,"timestamp":1744934105686},"delay":0,"floatShares":182695953,"shares":193917082,"eps":7.021558,"marketStatus":"Closed Good Friday","change":2.3,"latestTime":"04-17 16:00:00 EDT","open":283.01,"high":287.84,"low":281.65,"amount":463046451.32325,"amplitude":0.021762,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":7.021558,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1285214400000,"exchange":"NYSE","adjPreClose":284.44,"dividendRate":0.007254,"preHourTrading":{"tag":"盘前","latestPrice":284,"preClose":284.44,"latestTime":"09:15 EDT","volume":753,"amount":215100.07491,"timestamp":1744895704512},"postHourTrading":{"tag":"盘后","latestPrice":287.35,"preClose":286.74,"latestTime":"19:55 EDT","volume":58970,"amount":16911212.395,"timestamp":1744934105686},"volumeRatio":1.075020934860876,"impliedVol":0.2974,"impliedVolPercentile":0.9522},"requestUrl":"/m/hq/s/COR","defaultTab":"news","newsList":[{"id":"2528724378","title":"Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report?","url":"https://stock-news.laohu8.com/highlight/detail?id=2528724378","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528724378?lang=en_us&edition=full_marsco","pubTime":"2025-04-18 00:10","pubTimestamp":1744906212,"startTime":"0","endTime":"0","summary":"Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report?Cencora , which belongs to the Zacks Medical Services industry, could be a great candidate to consider.This prescription drug distributor has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 5.31%.For the last reported quarter, Cencora came out with earnings of $3.73 per share versus the Zacks Consensus Estimate of $3.50 per share, representing a surprise of 6.57%. For the previous quarter, the company was expected to post earnings of $3.21 per share and it actually produced earnings of $3.34 per share, delivering a surprise of 4.05%.With this earnings history in mind, recent estimates have been moving higher for Cencora. In fact, the Zacks Earnings ESP  for the company is positive, which is a great sign of an earnings beat, esp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cencora-cor-beat-estimates-again-161012419.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["COR"],"gpt_icon":0},{"id":"2528797056","title":"Citi Keeps Their Buy Rating on Cencora (COR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2528797056","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528797056?lang=en_us&edition=full_marsco","pubTime":"2025-04-17 18:59","pubTimestamp":1744887548,"startTime":"0","endTime":"0","summary":"Citi analyst Daniel Grosslight maintained a Buy rating on Cencora (COR – Research Report) today and set a price target of $330.00. The company’s sh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-keeps-their-buy-rating-on-cencora-cor?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-keeps-their-buy-rating-on-cencora-cor?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COR"],"gpt_icon":0},{"id":"2528292792","title":"Cencora : Citigroup Raises Target Price to $330 From $295","url":"https://stock-news.laohu8.com/highlight/detail?id=2528292792","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528292792?lang=en_us&edition=full_marsco","pubTime":"2025-04-17 18:44","pubTimestamp":1744886681,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QV1ZL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1119994496.HKD","LU2237957811.SGD","BK4529","COR","LU1084165304.USD","LU0058720904.USD","LU2237957902.USD","SGXZ23171101.USD","BK4084","LU0289739699.SGD","BK4585","BK4588","LU1585245621.USD","LU2324357040.USD","LU1430594728.SGD","BK4175","LU1261432733.SGD","SG9999004303.SGD"],"gpt_icon":0},{"id":"2527214785","title":"Baird Adjusts Price Target on Cencora to $314 From $308, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2527214785","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527214785?lang=en_us&edition=full_marsco","pubTime":"2025-04-16 20:52","pubTimestamp":1744807922,"startTime":"0","endTime":"0","summary":"Cencora (COR) has an average rating of overweight and mean price target of $298, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks a","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["COR"],"gpt_icon":0},{"id":"2527525939","title":"U.S. RESEARCH ROUNDUP-3M, Citigroup, Nvidia","url":"https://stock-news.laohu8.com/highlight/detail?id=2527525939","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527525939?lang=en_us&edition=full_marsco","pubTime":"2025-04-16 15:47","pubTimestamp":1744789663,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-3M, Citigroup, Nvidia April 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including 3M, Citigroup and N","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nL4N3QU0JT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DOV","IE00B42XCP33.USD","BOW","BXMT","BK4533","KRRO","EMR","MMM","CARR","BMI","CGON","LU0256863902.USD","CCNE","FLS","FTV","FLNC","GTES","IEX","IE00BQXX3F31.USD","GGG","LU2468319806.SGD","LU1721427968.SGD","NLY","LU1934455863.HKD","COR","IE00BN0W2T93.GBP","LU0640476718.USD","HON","ABR","CPAY","FBK","BE","IBKR","ARI","HWC","AGNC","EPAM","LNN","LU1496350171.SGD","MCK","AXTA","GO","ATO","AME","LII","AOS","JBHT","KREF","CAH"],"gpt_icon":1},{"id":"2527344424","title":"Morgan Stanley Adjusts Cencora Price Target to $288 From $263, Maintains Equal Weight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2527344424","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527344424?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 23:43","pubTimestamp":1744731834,"startTime":"0","endTime":"0","summary":"Cencora (COR) has an average rating of overweight and mean price target of $294.21, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["COR"],"gpt_icon":0},{"id":"2527191556","title":"BAX Stock Declines Despite Latest Product Launch Boosting Patient Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2527191556","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527191556?lang=en_us&edition=full_marsco","pubTime":"2025-04-14 21:48","pubTimestamp":1744638480,"startTime":"0","endTime":"0","summary":"Baxter International Inc. BAX, on Thursday, announced the introduction of Hemopatch Sealing Hemostat with room temperature storage. It is a ready-to-use absorbable collagen pad intended for tissue sealing, dura sealing and hemostasis .Per Baxter, the Hemopatch Sealing Hemostat is effective and safe for use in open surgery and minimally invasive surgery. It is currently available to order throughout Europe.The Hemopatch Sealing Hemostat has been used by surgeons as a reliable solution for tissue sealing, dura sealing and hemostasis for a long period of time. The product now includes the innovation of including room temperature storage, which resulted from the collaboration between surgeons and Baxter.With the latest product innovation, BAX aims to boost its Advanced Surgery business under the broader Medical Products & Therapies segment and promote enhanced patient care.Following the announcement, shares of the company lost nearly 9.5% till last trading.Per Baxter, the evolution of the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bax-stock-declines-despite-latest-134800910.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0234572021.USD","IE00B2B36J28.USD","LU1084165304.USD","BK4588","IE00BJT1NW94.SGD","LU1989763427.SGD","IE0009355771.USD","BK4566","BK4581","LU0266013472.USD","LU0310799852.SGD","LMAT","SGXZ23171101.USD","LU2098885051.SGD","LU1691799644.USD","ABT","BAX","LU0122379950.USD","IE0002141913.USD","LU0162691827.USD","LU0006061336.USD","LU0058720904.USD","LU0170899867.USD","BK4585","IE00B4R5TH58.HKD","LU1023059063.AUD","LU1267930490.SGD","LU2237957811.SGD","LU0289739699.SGD","LU2324357040.USD","COR","LU1989763690.USD","SG9999002224.SGD","LU1261432733.SGD","BK4529","LU2089984988.USD","SG9999002232.USD","LU0072461881.USD","LU2468319806.SGD","LU1914381329.SGD","LU2112291526.USD","BK4568","LU0868494617.USD","BK4533","BK4175","LU0211327993.USD","SG9999004303.SGD","LU1430594728.SGD","IE00BFTCPJ56.SGD","LU1721429402.USD"],"gpt_icon":0},{"id":"2527167619","title":"Beat the Market the Zacks Way: Casey's, Stride, McDonald's in Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2527167619","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527167619?lang=en_us&edition=full_marsco","pubTime":"2025-04-14 20:02","pubTimestamp":1744632120,"startTime":"0","endTime":"0","summary":"Last Friday, the three most widely followed benchmark indexes closed a volatile yet winning week. The Nasdaq Composite, the S&P 500 and the Dow Jones Industrial Average advanced 7.3%, 5.7% and 5%, respectively.Throughout the week, trade was influenced by tariff reprieves announced on European goods and a trade war between the United States and China. The S&P 500 and the Dow registered their biggest weekly percentage gains since November 2023, and the tech-focused Nasdaq claimed its biggest advance since November 2022. For March, inflation numbers both on the consumer and producer side came in negative, against expectations.Consumer sentiments, however, have declined further, and all eyes are currently set on developments from the White House and its multi-front tariff war.Regardless of market conditions, we, here at Zacks, provide investors with unbiased guidance on how to beat the market.As usual, Zacks Research guided investors over the past three months with its time-tested methodol","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/beat-market-zacks-way-caseys-120200040.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BFSS8Q28.SGD","UNH","LU0417517546.SGD","AMT","OEF","NOBL","SH","SG9999002232.USD","LU2112291526.USD","IE00B19Z9505.USD","LU0942090050.USD","MCD","OEX","CASY","ECDP","LU1066051225.USD","LU1037948541.HKD","LU0965508806.USD","LU0965509101.SGD","HEINY","LU2361044949.HKD","LU1291159041.SGD","PLMR","LU1674673428.USD","VOO","LU2361044865.SGD","ESmain","CHKP","MURGY","SDS","SPY","LU2028103732.USD","IE00BSNM7G36.USD","IE0009355771.USD","SSO","BK4154","LU2133065610.SGD","COR","LU0211326755.USD","LRN","LU0496365809.HKD",".SPX","FDN","IE00B7KXQ091.USD","LU0976567544.SGD","SFM","LU0251132253.USD","IVV"],"gpt_icon":1},{"id":"2526649782","title":"Cencora Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2526649782","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526649782?lang=en_us&edition=full_marsco","pubTime":"2025-04-12 04:46","pubTimestamp":1744404360,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Cencora Inc.  advanced 1.86% to $284.33 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 1.81% to 5,363.36 and the Dow Jones Industrial Average  rising 1.56% to 40,212.71.This was the stock's second consecutive day of gains.Cencora Inc. closed 4.15% short of its 52-week high of $296.65, which the company achieved on April 4th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Amazon.com Inc.  rose 2.01% to $184.87, UnitedHealth Group Inc.  rose 0.85% to $599.47, and CVS Health Corp.  rose 0.78% to $69.51.Trading volume  remained 398,335 below its 50-day average volume of 1.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 11, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently fr","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COR"],"gpt_icon":0},{"id":"2526666313","title":"Cencora Is Maintained at Neutral by B of A Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2526666313","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526666313?lang=en_us&edition=full_marsco","pubTime":"2025-04-11 20:22","pubTimestamp":1744374120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/COR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 11, 2025 08:22 ET (12:22 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COR"],"gpt_icon":0},{"id":"2526592433","title":"Here's Why You Should Add Cencora Stock to Your Portfolio Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2526592433","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526592433?lang=en_us&edition=full_marsco","pubTime":"2025-04-10 19:25","pubTimestamp":1744284300,"startTime":"0","endTime":"0","summary":"Cencora, Inc. COR is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches. However, intense competition is a concern.Shares of this Zacks Rank #2  company have risen 21.9% so far this year against the industry’s 5.5% decline. The S&P 500 Index has decreased 15.6% in the same time frame.Cencora is one of the world’s largest pharmaceutical service companies. It is focused on providing drug distribution and related services to reduce healthcare costs and improve patient outcomes. The company has a market capitalization of $53.27 billion.COR’s bottom line is anticipated to improve 12.1% over the next five years. Its earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 4.94%.Internationally, revenues rose 5.5% despite currency challenges, supported by the European and Canadian markets. However, the International segment’s operating income declined due to lower operating income at COR’s global special","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-add-cencora-stock-112500173.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4533","BK4534","COR","LU1914381329.SGD","IE00BFTCPJ56.SGD","LU2112291526.USD","IE0009355771.USD","IE00B2B36J28.USD","LU2720916845.USD","SG9999002224.SGD","LU1261432733.SGD","LU0868494617.USD","BK4588","LU1119994496.HKD","SGXZ23171101.USD","BK4084","LU2237957811.SGD","LU0205194284.USD","BK4504","LU2023250504.SGD","LU0234572021.USD","LU0058720904.USD","LU2764262908.HKD","LU0205193047.USD","LU1721429741.USD","LU2468319806.SGD","MASI","SG9999004303.SGD","IE00B4R5TH58.HKD","LU2133065610.SGD","LU1430594728.SGD","IE00BJJMRZ35.SGD","LU1721429402.USD","IE00BJT1NW94.SGD","LU2764263039.SGD","LU0289739699.SGD","BK4592","BK4529","LU1989763427.SGD","LU0266013472.USD","LU2237957902.USD","LU1057294990.SGD","LU2023250843.SGD","LU1023059063.AUD","LU1691799644.USD","BK4581","LU1061106388.HKD","ALGN","ABT"],"gpt_icon":1},{"id":"2526393747","title":"Top 3 MedTech Stocks to Weather the Trump Tariff Turbulence","url":"https://stock-news.laohu8.com/highlight/detail?id=2526393747","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526393747?lang=en_us&edition=full_marsco","pubTime":"2025-04-09 20:57","pubTimestamp":1744203420,"startTime":"0","endTime":"0","summary":"President Donald Trump’s new set of extensive tariffs on nearly all of America’s trading partners, at a minimum of 10%, are already in effect. Added to that, tariffs went as high as 50% for a few nations. Major trading partners like China, Japan, Taiwan, South Korea and India are facing steep “reciprocal” tariffs. Trump's implementation of these tariffs represents the most significant escalation in U.S. tariffs in nearly a century.This move has caused significant fluctuations in the market, raising alarms about the possibility of a full-scale trade war. Moreover, implementing these tariffs could disrupt worldwide supply chains and elevate business expenses. Furthermore, a scenario featuring both inflation and recession in the United States seems quite likely. JP Morgan upgrades its projection for a global recession in 2025 to 60%. It anticipates a recession in the United States this year, spurred by the new tariffs, forecasting a GDP decline of 0.3% and an unemployment rate of 5.3%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/top-3-medtech-stocks-weather-125700594.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","FMS","LU2237957902.USD","LU1430594728.SGD","LU2237957811.SGD","SGXZ23171101.USD","LU1585245621.USD","LU1119994496.HKD","BK4585","BK4175","LU1084165304.USD","BK4084","LU1261432733.SGD","LU0058720904.USD","BK4529","BK4196","LU0289739699.SGD","SG9999004303.SGD","BK4007","COR","PAHC","LU2324357040.USD"],"gpt_icon":0},{"id":"2526394428","title":"Indonesia, France to Expand Cooperation in Land, Maritime, and Air Transport","url":"https://stock-news.laohu8.com/highlight/detail?id=2526394428","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526394428?lang=en_us&edition=full_marsco","pubTime":"2025-04-09 19:59","pubTimestamp":1744199975,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta - Transportation Minister Dudy Purwagandhi welcomed French Minister of Foreign Trade Delegation Laurent Saint-Martin during a visit to his office on Wednesday, April 9, 2025. The two discussed potential cooperation across land, sea, and air transportation sectors.Beyond advancing transportation technology, Minister Dudy highlighted human resource development as a key area of collaboration.He emphasized that knowledge transfer from France could be facilitated through training programs, competency-based education, and vocational studies at polytechnics and academies under the Ministry of Transportation.“Indonesia is committed to strengthening its transportation partnership with France. This discussion is intended to ensure the collaboration delivers real benefits for both countries,” Dudy said in a written statement received by Tempo.As for the discussion on collaboration in the land transportation sector, it is related to the improvement of infrastructure and public tr","market":"fut","thumbnail":"https://statik.tempo.co/data/2025/04/09/id_1390512/1390512_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2025/04/09/id_1390512/1390512_720.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/1995027/indonesia-france-to-expand-cooperation-in-land-maritime-and-air-transport","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK4585","LU2237957902.USD","LU1585245621.USD","LU1119994496.HKD","SGXZ23171101.USD","BK4215","LU1261432733.SGD","SG9999004303.SGD","COR","LU0289739699.SGD","BK4131","BK4175","LU1084165304.USD","BK4084","BRT","LU0058720904.USD","BK4588","LU2237957811.SGD","LU2324357040.USD","ATSG","BK4529","BK4572","LU1430594728.SGD"],"gpt_icon":0},{"id":"2526284698","title":"ICUI Stock Gains Following Latest FDA Approvals for Precision IV Pumps","url":"https://stock-news.laohu8.com/highlight/detail?id=2526284698","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526284698?lang=en_us&edition=full_marsco","pubTime":"2025-04-09 00:04","pubTimestamp":1744128240,"startTime":"0","endTime":"0","summary":"ICU Medical, Inc. ICUI, yesterday, announced the FDA’s 510 clearance for the Plum Solo precision IV pump, a single-channel complement to the dual-channel Plum Duo. The company also received the 510 clearance for updated versions of the Plum Duo precision IV pump and LifeShield infusion safety software, completing the initial launch of the ICU Medical IV Performance Platform.The Plum Solo expands the capabilities of the IV Performance Platform by offering a single-channel pump designed to work alongside the dual-channel Plum Duo.With these FDA clearances, ICUI aims to introduce its new category of precision IV pumps and expand the ICU Medical IV Performance Platform.Shares of the company have gained 37.9% in the past year compared with the industry’s 0.3% rise. The S&P 500 has lost 2.3% in the same time frame.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/icui-stock-gains-following-latest-160400882.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SG9999015952.SGD","LU0106261612.USD","LU2362540622.SGD","BK4585","LU0234572021.USD","LU1721429741.USD","LU1261432733.SGD","LU1721429402.USD","LU2237957902.USD","LU2133065610.SGD","LU2362541513.USD","LU0823417737.USD","LU2087625088.SGD","ICUI","BK4504","LU2506951875.HKD","LU0170899867.USD","LU1983299246.USD","IE00B4R5TH58.HKD","LU1061106388.HKD","LU1718418525.SGD","LU1914381329.SGD","LU1989771016.USD","BK4529","BK4084","LU0950375773.USD","SG9999002224.SGD","IE00B2B36J28.USD","LU1585245621.USD","LU0289739699.SGD","BSX","LU2506952097.USD","ABT","LU2506951958.HKD","LU2362541273.HKD","LU0012050646.USD","LU2089984988.USD","IE00BFTCPJ56.SGD","LU2491050154.USD","LU1804176565.USD","COR","IE00BJJMRZ35.SGD","LU0823417653.USD","LU1989772923.USD","LU0225283273.USD","LU0353189680.USD","LU2506952170.USD","LU0205193047.USD","LU1084165304.USD","BK4566"],"gpt_icon":0},{"id":"2525071664","title":"Cencora Inc. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2525071664","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525071664?lang=en_us&edition=full_marsco","pubTime":"2025-04-08 04:44","pubTimestamp":1744058640,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Cencora Inc.  slid 1.38% to $274.56 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.23% to 5,062.25 and Dow Jones Industrial Average  falling 0.91% to 37,965.60.This was the stock's second consecutive day of losses.Cencora Inc. closed 7.45% short of its 52-week high of $296.65, which the company achieved on April 4th.The stock underperformed when compared to some of its competitors Monday, as Amazon.com Inc.  rose 2.49% to $175.26, UnitedHealth Group Inc.  fell 0.07% to $524.70, and CVS Health Corp.  rose 0.30% to $63.85.Trading volume  eclipsed its 50-day average volume of 1.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 7, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COR"],"gpt_icon":0},{"id":"2525524043","title":"Here's Why You Should Hold Accuray Stock in Your Portfolio for Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2525524043","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525524043?lang=en_us&edition=full_marsco","pubTime":"2025-04-07 19:45","pubTimestamp":1744026300,"startTime":"0","endTime":"0","summary":"Accuray IncorporatedARAY is well-poised for growth in the coming quarters, courtesy of continued robust demand for its products. The optimism, led by strong global performance in thesecond quarter of fiscal 2025 and potential in the Radiosurgery Market, is expected to contribute further. However, reimbursement uncertainties and challenges related to FX impacts are concerning.This Zacks Rank #3  company’s shares have lost 20.7% so far this year compared with a 13.2% decline in theindustry. The S&P 500 has witnessed a 14.1% decrease in the said time frame.The renowned radiation oncology company has a market capitalization of $161.4 million. Accuray predicts 106.3% growth for fiscal 2025 and expects to maintain its strong performance going forward. The company has a P/S ratio of 0.4X compared with the industry’s 2.5X.In the fiscal second quarter, CyberKnife’s strong performance led to revenue growth of over 50% year over year, significantly exceeding overall market growth. Management attr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-hold-accuray-stock-114500403.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0353189763.USD","MASI","BK4175","LU0240878834.USD","LU1718418525.SGD","LU2362541273.HKD","LU1989772840.SGD","LU1061106388.HKD","SG9999004303.SGD","LU0823416689.USD","IE0002141913.USD","LU1585245621.USD","LU2491050154.USD","LU1989772923.USD","LU2362541513.USD","LU1057294990.SGD","LU0240877869.USD","LU1989764748.USD","ARAY","LU0823417737.USD","LU2362540622.SGD","IE00BJJMRZ35.SGD","LU0528227936.USD","LU2506952170.USD","LU2506951958.HKD","BK4529","IE00BJT1NW94.SGD","LU0289739699.SGD","LU1084165304.USD","IE00BFTCPJ56.SGD","COR","LU0238689110.USD","LU2506952097.USD","IE0009355771.USD","LU0353189680.USD","LU0077335932.USD","LU1983299246.USD","IE00B4R5TH58.HKD","LU0187121727.USD","BK4082","LU1791710400.SGD","LU1023059063.AUD","LU0205194284.USD","LU0823417653.USD","LU2764263039.SGD","LU1261432733.SGD","BK4588","LU2764262908.HKD","LU2112291526.USD","BSX"],"gpt_icon":0},{"id":"2525975019","title":"McKesson Gets Drugs to Patients. Buy the Stock. -- Barron's","url":"https://stock-news.laohu8.com/highlight/detail?id=2525975019","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525975019?lang=en_us&edition=full_marsco","pubTime":"2025-04-05 09:30","pubTimestamp":1743816600,"startTime":"0","endTime":"0","summary":"An aging U.S. population is increasing the demand for medication, and this company delivers. By Teresa Rivas and Al Root. -- McKesson has consistently grown ahead of the broader market in recent. -- The stock's steady earnings should attract safety-minded investors in the. From broken wine glasses to vertical pizza, everyone has a delivery horror story. When it comes to more-crucial items, there's less margin for error. McKesson transports vital medications safely and quickly -- and delivers healthy returns for investors, too.The Irving, Texas--based company is the largest drug distributor in the nation, generating hundreds of billions in annual sales from dozens of distribution centers. With an aging population, and more Americans taking GLP-1 weight-loss drugs, increasing demand for medication has led to increasing profits. Shares have jumped 45% since Barron's recommended them in October 2023.Profit margins are razor thin, at about 1%.  But that means McKesson is rarely in the firin","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0052756011.USD","BK4588","LU0965508806.USD","LU0122379950.USD","LU2237957902.USD","LU1057294990.SGD","LU1430594728.SGD","LU0310800965.SGD","LU0006061336.USD","LU0792757196.USD","LU2468319806.SGD","MCK","LU0889566641.SGD","LU0048573561.USD","LU1061106388.HKD","LU1267930490.SGD","LU0742534661.SGD","LU0128525689.USD","LU0965509010.AUD","LU1585245621.USD","LU0868494617.USD","LU0211328371.USD","LU1934455194.USD","LU1119994496.HKD","LU1880398554.USD","BK4585","CAH","BK4175","LU1084165304.USD","SG9999001440.SGD","LU1023059063.AUD","LU0251131958.USD","LU1261432733.SGD","LU0058720904.USD","LU0251142724.SGD","BK4529","LU1037948541.HKD","LU0310799852.SGD","SG9999004303.SGD","LU0965509101.SGD","LU0861579265.USD","COR","LU2112291526.USD","LU0154236417.USD","LU0162691827.USD","LU1880398471.USD","LU1267930813.SGD","LU1571399168.USD","LU1814569148.SGD","LU2324357040.USD"],"gpt_icon":0},{"id":"2525505736","title":"3 Stocks Defying Trump's Tariff Shock -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2525505736","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525505736?lang=en_us&edition=full_marsco","pubTime":"2025-04-05 01:46","pubTimestamp":1743788760,"startTime":"0","endTime":"0","summary":"Looking for safety amid the market's tariff-induced sell off?The S&P 500's three top performers in 2025 -- CVS Health, Philip Morris International, and Cencora -- have gained more than 28% so far this year. While these names have rallied for company-specific reasons, they also boast characteristics that could help them weather a further sell off.The S&P 500 was down 5.3% Friday as China retaliated against President Donald Trump's aggressive tariff stance. All in all, the benchmark has tumbled 9.7% since tariffs were announced Wednesday afternoon.The market's 2025 leaders have held up comparatively well, thanks in part to their defensive character. CVS Health is down about 5.8% during that time; Philip Morris International fell 2.7%, while Cencora was actually up by 0.1%, according to Dow Jones Markets Data.Nelson, who rates the stock a \"Buy,\" added in an email Friday that Philip Morris International should be relatively","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVS","BK4566","BK4534","OEX","MCK","BK4581","ESmain",".SPX","BK4175","LU0965509283.SGD","LU0006061336.USD","IE00BKVL7J92.USD","SG9999001440.SGD","BK4533","LU1043141396.HKD","OEF","VOO","IE00B19Z3B42.SGD","PM","LU0048573561.USD","LU0742534661.SGD","IE0002270589.USD","SSO","LU1023059063.AUD","LU2237957902.USD","IE00B19Z3581.USD","LU1043141123.HKD","LU1506573853.SGD","LU2112291526.USD","SH","SPY","LU0690374961.EUR","LU0122379950.USD","SPXU","LU0320765489.SGD","IVV","LU0965509101.SGD","LU0289739699.SGD","LU1228905037.USD","IE00BSNM7G36.USD","LU0251142724.SGD","LU1934455863.HKD","SDS","LU1261432733.SGD","COR","GB00B4LPDJ14.GBP","LU1037948897.HKD","MO","LU0942090050.USD"],"gpt_icon":1},{"id":"2525352734","title":"Danaher Gains From Strength in the Diagnostics Unit Amid Headwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=2525352734","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525352734?lang=en_us&edition=full_marsco","pubTime":"2025-04-04 23:57","pubTimestamp":1743782220,"startTime":"0","endTime":"0","summary":"Despite the positives, sluggish demand across pharma and biotech markets in China has been weighing on Danaher’s Instrument businesses under the Life Sciences segment. The company has been witnessing a sales decline in mass spectrometry, flow cytometry & lab automation solutions and microscopy businesses due to soft demand for equipment in major end markets. Core revenues from the Life Sciences segment declined 2% on a year-over-year basis in 2024.Also, weakness in the company’s Biotechnology segment raises concerns. Sluggish demand in the discovery and medical business has been weighing on the performance of the Biotechnology segment. The segment’s core revenues declined 4.5% on a year-over-year basis in 2024.High debt levels have also been a concern for Danaher. It exited fourth-quarter 2024 with a long-term debt of $15.5 billion. Its current liabilities were $6.8 billion, higher than the cash equivalents of $2.1 billion. Also, interest expenses in 2024 remained high at $278 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/danaher-gains-strength-diagnostics-unit-155700461.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0289739699.SGD","EHAB","LU1430594728.SGD","LU2125909593.SGD","LU1023059063.AUD","LU1923622614.USD","BK4504","LU0820561909.HKD","LU1057294990.SGD","BK4196","LU0289960550.SGD","LU0511384066.AUD","LU0528227936.USD","LU1084165304.USD","LU1974910355.USD","BK4533","DHR","BK4581","LU0390134368.USD","BK4121","LU0882574055.USD","LU2063271972.USD","MD","COR","IE00BZ1G4Q59.USD","LU2355687059.USD","LU1061106388.HKD","LU1917777945.USD","LU1119994496.HKD","LU2237957811.SGD","BK4534","LU2125909247.SGD","LU2237957902.USD","BK4588","LU0943347566.SGD","LU0289739343.SGD","LU1267930730.SGD","LU2125910179.SGD","SGXZ57979304.SGD","LU1791710400.SGD","LU0689472784.USD","LU0708995401.HKD","SG9999001176.USD","BK4529","LU0320765059.SGD","BK4175","LU1923621640.USD","LU2106854487.HKD","LU2324357040.USD","LU0058720904.USD"],"gpt_icon":0},{"id":"2524742204","title":"Sandoz Faces Information-Sharing Probe in Spain","url":"https://stock-news.laohu8.com/highlight/detail?id=2524742204","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524742204?lang=en_us&edition=full_marsco","pubTime":"2025-04-04 21:26","pubTimestamp":1743773160,"startTime":"0","endTime":"0","summary":"Spain's competition watchdog opened an investigation into whether drug makers including Sandoz and its subsidiary Bexal   broke antitrust rules by sharing sensitive commercial information.The probe, which also involves Cencora-owned Alliance Healthcare Espana as well as Bluetab Solutions, is looking into whether the companies shared sensitive information about orders of Sandoz and Bexal generic medicines placed by some drug stores, the regulator known as the CNMC said Friday.The investigation covers the period between April 2018 and April 2023 and focuses on whether information was exchanged directly between Sandoz and Alliance, or indirectly through Bluetab, without the prior knowledge or consent of the drug stores affected, the CNMC said.The CNMC inspected the Spanish headquarters of Sandoz, Bexal, Alliance and Bluetab in November 2023 following a complaint being made against the companies, it said.There is a time limit of 24 months to reach a decision on the case, it added.None of t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","SGXZ23171101.USD","BK4588","LU1119994496.HKD","III","SG9999004303.SGD","LU2237957811.SGD","LU1261432733.SGD","LU1084165304.USD","LU1585245621.USD","BK4134","LU0058720904.USD","LU2324357040.USD","BK4084","LU0289739699.SGD","BK4529","LU2237957902.USD","BK4585","COR","BK4175"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cencora.com","stockEarnings":[{"period":"1week","weight":0.0272},{"period":"1month","weight":0.0856},{"period":"3month","weight":0.1846},{"period":"6month","weight":0.2077},{"period":"1year","weight":0.2017},{"period":"ytd","weight":0.2762}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"","yearOnYearQuotes":[{"month":1,"riseRate":0.793103,"avgChangeRate":0.049548},{"month":2,"riseRate":0.551724,"avgChangeRate":-0.002452},{"month":3,"riseRate":0.586207,"avgChangeRate":0.009147},{"month":4,"riseRate":0.586207,"avgChangeRate":0.01564},{"month":5,"riseRate":0.642857,"avgChangeRate":0.025214},{"month":6,"riseRate":0.517241,"avgChangeRate":0.029089},{"month":7,"riseRate":0.586207,"avgChangeRate":0.014597},{"month":8,"riseRate":0.586207,"avgChangeRate":-0.010675},{"month":9,"riseRate":0.517241,"avgChangeRate":0.023105},{"month":10,"riseRate":0.551724,"avgChangeRate":-0.00923},{"month":11,"riseRate":0.689655,"avgChangeRate":0.030742},{"month":12,"riseRate":0.551724,"avgChangeRate":0.017093}],"exchange":"NYSE","name":"Cencora Inc.","nameEN":"Cencora Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cencora Inc.(COR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Cencora Inc.(COR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Cencora Inc.,COR,Cencora Inc.股票,Cencora Inc.股票老虎,Cencora Inc.股票老虎国际,Cencora Inc.行情,Cencora Inc.股票行情,Cencora Inc.股价,Cencora Inc.股市,Cencora Inc.股票价格,Cencora Inc.股票交易,Cencora Inc.股票购买,Cencora Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cencora Inc.(COR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Cencora Inc.(COR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}